From one of the world’s oldest general medical journals – the prospect of vaccines avoiding the harm and misery of extended restrictions is a cause for optimism, but we are far from ending COVID-19 as a public health issue. The vaccine trials’ results were announced via press releases, leaving many scientific uncertainties that will dictate how the vaccines will affect the course of the pandemic. Peer-reviewed publication should resolve these issues, but other questions will not be answerable for some time.

US-China relations after Trump – disappointment awaits businesses who hope to see Joe Biden rushing to cancel the tariffs that Donald Trump imposed on imports from China. To maintain leverage, Biden has an interest in dismantling Trump’s trade barriers only cautiously.

American capitalism faces the question of the nature and degree of change necessary to ensure growth and prosperity for all in the 21st century. It has evolved time and again, and we may be poised for another such shift. Will the future of capitalism involve tweaks, reforms, or wholesale change?

Although risk professionals are aware of the dangers that an unpredictable political environment can pose to their organisation, identifying and assessing those risks is the challenge that faces our profession today. This report will help break down the risks, understand their interconnectivity, the solutions available and appropriate responses.